Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors There were 68 randomized trials included in the ...
Systemic sclerosis is an autoimmune disease that is characterized by the distinctive pathogenetic triad of microvascular damage, dysregulation of innate and adaptive immunity, and generalized fibrosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback